CeCurio (MVZ Tübingen oncology)
CeCurio, the oncology and haematology practice of MVZ Tübingen, offers personalised peptide vaccines built with the sequencing laboratory CeGaT, with real-world survival data in glioblastoma.
Overview
The oncology and haematology practice at MVZ Tübingen offers personalised cancer therapy and advanced diagnostics, including personalised peptide vaccines developed in collaboration with CeGaT; Future of Cancer Care Today notes real-world survival data in glioblastoma and lists it as patient-bookable in Germany.
Similar pages
not linked directly; found by shared links- InstitutionHouston Methodist Center for RNA Therapeutics
Shares Personalised neoantigen (mRNA) vaccines and the tag fcct-directory.
- CompanyInvoke Bio
Shares Personalised neoantigen (mRNA) vaccines and the tag fcct-directory.
- CompanyJaime Leandro Foundation
Shares Personalised neoantigen (mRNA) vaccines and the tag fcct-directory.
- CompanyUbiVac
Shares Personalised neoantigen (mRNA) vaccines and the tag fcct-directory.
- CompanyCeGaT
Shares Personalised neoantigen (mRNA) vaccines and the tag fcct-directory.
- CompanyBelay Diagnostics
Shares Glioma & glioblastoma and the tag fcct-directory.
- CompanyDiakonos Oncology
Shares Glioma & glioblastoma and the tag fcct-directory.
- CompanyKiyatec
Shares Glioma & glioblastoma and the tag fcct-directory.